Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study
- PMID: 32770267
- DOI: 10.1007/s00134-020-06184-2
Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study
Erratum in
-
Correction to: Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study.Intensive Care Med. 2021 Feb;47(2):259-260. doi: 10.1007/s00134-020-06252-7. Intensive Care Med. 2021. PMID: 33006683 No abstract available.
Abstract
Purpose: To describe trends in outcomes of cancer patients with unplanned admissions to intensive-care units (ICU) according to cancer type, organ support use, and performance status (PS) over an 8-year period.
Methods: We retrospectively analyzed prospectively collected data from all cancer patients admitted to 92 medical-surgical ICUs from July/2011 to June/2019. We assessed trends in mortality through a Bayesian hierarchical model adjusted for relevant clinical confounders and whether there was a reduction in ICU length-of-stay (LOS) over time using a competing risk model.
Results: 32,096 patients (8.7% of all ICU admissions; solid tumors, 90%; hematological malignancies, 10%) were studied. Bed/days use by cancer patients increased up to more than 30% during the period. Overall adjusted mortality decreased by 9.2% [95% credible interval (CI), 13.1-5.6%]. The largest reductions in mortality occurred in patients without need for organ support (9.6%) and in those with need for mechanical ventilation (MV) only (11%). Smallest reductions occurred in patients requiring MV, vasopressors, and dialysis (3.9%) simultaneously. Survival gains over time decreased as PS worsened. Lung cancer patients had the lowest decrease in mortality. Each year was associated with a lower sub-hazard for ICU death [SHR 0.93 (0.91-0.94)] and a higher chance of being discharged alive from the ICU earlier [SHR 1.01 (1-1.01)].
Conclusion: Outcomes in critically ill cancer patients improved in the past 8 years, with reductions in both mortality and ICU LOS, suggesting improvements in overall care. However, outcomes remained poor in patients with lung cancer, requiring multiple organ support and compromised PS.
Keywords: Bayesian analysis; Cancer; Critical care; Mortality trends; Multicenter study.
References
-
- Azoulay E, Schellongowski P, Darmon M et al (2017) The intensive care medicine research agenda on critically ill oncology and hematology patients. Intensive Care Med 43:1366–1382. https://doi.org/10.1007/s00134-017-4884-z - DOI - PubMed
-
- Puxty K, McLoone P, Quasim T et al (2015) Risk of critical illness among patients with solid cancers: a population-based observational study. JAMA Oncol 1:1078–1085. https://doi.org/10.1001/jamaoncol.2015.2855 - DOI
-
- Soares M, Bozza FA, Azevedo LCP et al (2016) Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care units. J Clin Oncol Off J Am Soc Clin Oncol 34:3315–3324. https://doi.org/10.1200/JCO.2016.66.9549 - DOI
-
- Shimabukuro-Vornhagen A, Böll B, Kochanek M et al (2016) Critical care of patients with cancer. CA Cancer J Clin 66:496–517. https://doi.org/10.3322/caac.21351 - DOI - PubMed
-
- Gutierrez C, McEvoy C, Munshi L et al (2020) Critical care management of toxicities associated with targeted agents and immunotherapies for cancer. Crit Care Med 48:10–21. https://doi.org/10.1097/CCM.0000000000004087 - DOI - PubMed - PMC
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
